{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:23:20Z","timestamp":1793057000669,"version":"4.5.0"},"reference-count":50,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.3201\/eid2611.191694","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T17:03:31Z","timestamp":1601399011000},"page":"2625-2637","source":"Crossref","is-referenced-by-count":28,"title":["Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever"],"prefix":"10.3201","volume":"26","author":[{"given":"Lucy E.","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Sakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mambu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Demby","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Schieffelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2611.191694-202010161837-R1","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview.","volume":"44","author":"Ogbu","year":"2007","journal-title":"J Vector Borne Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy.","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"key":"key-10.3201\/eid2611.191694-202010161837-R3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever.","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fpubh.2018.00232","article-title":"Lassa fever 2016 outbreak in Plateau State, Nigeria\u2013the changing epidemiology and clinical presentation.","volume":"6","author":"Shehu","year":"2018","journal-title":"Front Public Health"},{"key":"key-10.3201\/eid2611.191694-202010161837-R5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0035-9203(72)90268-4","article-title":"The pathology of Lassa fever.","volume":"66","author":"Edington","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid2611.191694-202010161837-R6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1010.IM1010","article-title":"On the front lines of Lassa fever.","volume":"10","author":"Bausch","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jmv.1890260204","article-title":"Hematologic dysfunction in Lassa fever.","volume":"26","author":"Fisher-Hoch","year":"1988","journal-title":"J Med Virol"},{"key":"key-10.3201\/eid2611.191694-202010161837-R8","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1371\/journal.pntd.0002858","article-title":"The role of platelets in the pathogenesis of viral hemorrhagic fevers.","volume":"8","author":"Zapata","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R9","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone.","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R10","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1016\/S0021-9258(18)34276-5","article-title":"Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.","volume":"257","author":"Esmon","year":"1982","journal-title":"J Biol Chem"},{"key":"key-10.3201\/eid2611.191694-202010161837-R11","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1172\/JCI112225","article-title":"Thrombomodulin is present in human plasma and urine.","volume":"76","author":"Ishii","year":"1985","journal-title":"J Clin Invest"},{"key":"key-10.3201\/eid2611.191694-202010161837-R12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/314829","article-title":"Review: infectious diseases and coagulation disorders.","volume":"180","author":"van Gorp","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R13","doi-asserted-by":"crossref","first-page":"367284","DOI":"10.4061\/2011\/367284","article-title":"Tissue factor, blood coagulation, and beyond: an overview.","volume":"2011","author":"Chu","year":"2011","journal-title":"Int J Inflam"},{"key":"key-10.3201\/eid2611.191694-202010161837-R14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/cc7026","article-title":"Tissue factor as an initiator of coagulation and inflammation in the lung.","volume":"12","author":"van der Poll","year":"2008","journal-title":"Crit Care"},{"key":"key-10.3201\/eid2611.191694-202010161837-R15","first-page":"433","article-title":"[The expression of plasminogen activator inhibitor-1 (PAI-1) gene in human astrocytomas]","volume":"27","author":"Bu","year":"1998","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"key-10.3201\/eid2611.191694-202010161837-R16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor.","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"key-10.3201\/eid2611.191694-202010161837-R17","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.21037\/cdt.2017.08.01","article-title":"Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis.","volume":"7","author":"Oklu","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"key-10.3201\/eid2611.191694-202010161837-R18","doi-asserted-by":"crossref","first-page":"e0134193","DOI":"10.1371\/journal.pone.0134193","article-title":"Effect of chronic blood transfusion on biomarkers of coagulation activation and thrombin generation in sickle cell patients at risk for stroke.","volume":"10","author":"Hyacinth","year":"2015","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2611.191694-202010161837-R19","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.thromres.2010.01.046","article-title":"Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.","volume":"125","author":"Chung","year":"2010","journal-title":"Thromb Res"},{"key":"key-10.3201\/eid2611.191694-202010161837-R20","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1073\/pnas.78.4.2249","article-title":"Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.","volume":"78","author":"Esmon","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2611.191694-202010161837-R21","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation.","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"key-10.3201\/eid2611.191694-202010161837-R22","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-05-578328","article-title":"Endothelial cell protein C receptor: a multiliganded and multifunctional receptor.","volume":"124","author":"Mohan Rao","year":"2014","journal-title":"Blood"},{"key":"key-10.3201\/eid2611.191694-202010161837-R23","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway.","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"key":"key-10.3201\/eid2611.191694-202010161837-R24","doi-asserted-by":"crossref","first-page":"23708","DOI":"10.1016\/S0021-9258(17)31573-9","article-title":"Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule.","volume":"269","author":"Ishiwata","year":"1994","journal-title":"J Biol Chem"},{"key":"key-10.3201\/eid2611.191694-202010161837-R25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.175.4.1147","article-title":"Characterization of GMP-140 (P-selectin) as a circulating plasma protein.","volume":"175","author":"Dunlop","year":"1992","journal-title":"J Exp Med"},{"key":"key-10.3201\/eid2611.191694-202010161837-R26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cca.2008.09.018","article-title":"Soluble P-selectin as a marker of in vivo platelet activation.","volume":"399","author":"Ferroni","year":"2009","journal-title":"Clin Chim Acta"},{"key":"key-10.3201\/eid2611.191694-202010161837-R27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1076029609344981","article-title":"Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.","volume":"17","author":"Mosad","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"key-10.3201\/eid2611.191694-202010161837-R28","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V83.6.1535.1535","article-title":"Plasma P-selectin is increased in thrombotic consumptive platelet disorders.","volume":"83","author":"Chong","year":"1994","journal-title":"Blood"},{"key":"key-10.3201\/eid2611.191694-202010161837-R29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/infdis\/jiv161","article-title":"Increased thrombopoiesis and platelet activation in hantavirus-infected patients.","volume":"212","author":"Connolly-Andersen","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R30","first-page":"543","article-title":"E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.","volume":"77","author":"Leeuwenberg","year":"1992","journal-title":"Immunology"},{"key":"key-10.3201\/eid2611.191694-202010161837-R31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-3083.2008.02029.x","article-title":"Soluble ICAM-1 and VCAM-1 as markers of endothelial activation.","volume":"67","author":"Videm","year":"2008","journal-title":"Scand J Immunol"},{"key":"key-10.3201\/eid2611.191694-202010161837-R32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1989.tb04321.x","article-title":"A plasma inhibitor of platelet aggregation in patients with Lassa fever.","volume":"72","author":"Cummins","year":"1989","journal-title":"Br J Haematol"},{"key":"key-10.3201\/eid2611.191694-202010161837-R33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4269\/ajtmh.1990.42.470","article-title":"A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever.","volume":"42","author":"Cummins","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2611.191694-202010161837-R34","doi-asserted-by":"crossref","first-page":"E7814","DOI":"10.1073\/pnas.1804674115","article-title":"Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics.","volume":"115","author":"Oldstone","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2611.191694-202010161837-R35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of Lassa fever in cynomolgus macaques.","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol J"},{"key":"key-10.3201\/eid2611.191694-202010161837-R36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis.","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2611.191694-202010161837-R37","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock.","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2611.191694-202010161837-R38","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.","volume":"196","author":"Hensley","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R39","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1091\/mbc.e07-04-0374","article-title":"Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.","volume":"18","author":"Rojek","year":"2007","journal-title":"Mol Biol Cell"},{"key":"key-10.3201\/eid2611.191694-202010161837-R40","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"key-10.3201\/eid2611.191694-202010161837-R41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.200104103","article-title":"Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.","volume":"155","author":"Kunz","year":"2001","journal-title":"J Cell Biol"},{"key":"key-10.3201\/eid2611.191694-202010161837-R42","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/JVI.79.10.5979-5987.2005","article-title":"Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.","volume":"79","author":"Kunz","year":"2005","journal-title":"J Virol"},{"key":"key-10.3201\/eid2611.191694-202010161837-R43","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1073\/pnas.1408148111","article-title":"Type I interferon is a therapeutic target for virus-induced lethal vascular damage.","volume":"111","author":"Baccala","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2611.191694-202010161837-R44","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys.","volume":"83","author":"Baize","year":"2009","journal-title":"J Virol"},{"key":"key-10.3201\/eid2611.191694-202010161837-R45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(01)01508-8","article-title":"Monitoring of clinical and laboratory data in two cases of imported Lassa fever.","volume":"4","author":"Schmitz","year":"2002","journal-title":"Microbes Infect"},{"key":"key-10.3201\/eid2611.191694-202010161837-R46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/320722","article-title":"Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever.","volume":"183","author":"Mahanty","year":"2001","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/1743-422X-8-478","article-title":"Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.","volume":"8","author":"Branco","year":"2011","journal-title":"Virol J"},{"key":"key-10.3201\/eid2611.191694-202010161837-R48","doi-asserted-by":"crossref","first-page":"S743","DOI":"10.1093\/clinids\/11.Supplement_4.S743","article-title":"Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted.","volume":"11","author":"Peters","year":"1989","journal-title":"Rev Infect Dis"},{"key":"key-10.3201\/eid2611.191694-202010161837-R49","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1160\/TH09-06-0357","article-title":"The role of the vascular endothelium in arenavirus haemorrhagic fevers.","volume":"102","author":"Kunz","year":"2009","journal-title":"Thromb Haemost"},{"key":"key-10.3201\/eid2611.191694-202010161837-R50","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/11\/19-1694_intro","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:31:17Z","timestamp":1732987877000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/26\/11\/19-1694_intro.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2611.191694","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}